Non-profit innovator
Gates Medical Research Institute
Develop
The Gates Medical Research Institute develops malaria vaccines and monoclonal antibodies, including the MAM01 PfCSP monoclonal antibody for malaria prevention and the MAV02 PfCSP FtNP vaccine candidate.
1
Endemic countries
1
U.S. states
2
Products and programs
About
What they do
The Gates Medical Research Institute develops malaria vaccines and monoclonal antibodies, including the MAM01 PfCSP monoclonal antibody for malaria prevention and the MAV02 PfCSP FtNP vaccine candidate.1,2 Its U.S. R&D is based in Cambridge, Massachusetts.2 Its malaria work is in the development stage, with MAM01 having completed Phase 1 clinical testing and MAV02 in preclinical development.2
In the United States
- Cambridge, MA2Research and development
Products and programs
In the field and in development
Where they work
Partnerships in 1 endemic country
U.S. partners
Who they work with in the United States
- University of Maryland School of Medicine, Center for Vaccine Development and Global Health2In the atlasBaltimore, Maryland
- In the atlas
- In the atlas
Sources
Where this comes from
- 1gatesmri.org
- 2Confirmed by the organization
- 3clinicaltrials.gov
- 4biospace.com